Global burden of disease and its risk factors for adults aged 70 and older across 204 countries and territories: a comprehensive analysis of the Global Burden of Disease Study 2021.

Publication date: Jul 02, 2025

The global older population has been rapidly increasing in recent decades, presenting substantial economic and social challenges. This study aims to examine the global disease burden and the associated risk factors among the population aged 70 and older across different regions. Data from the Global Burden of Disease Study (GBD) database were used to analyze global deaths, disability-adjusted life years (DALYs), and average annual percentage changes to assess disease burden and associated risk factors. In 2021, the global population aged 70 and older reached 494. 4 (95%UI 482. 1-508. 2) million. Death and DALY rates have declined by 9. 2% (95%CI 5. 3-12. 7) and 11. 0% (95%CI 7. 7-14. 0) from 1990 to 2021, respectively. However, the global death rate increased to 7,062 per 100,000 population, with DALY rates rising to 125,042 per 100,000. A strong correlation exists between socio-demographic index (SDI) and DALY rates. Regions with lower SDI levels, particularly low and low-middle SDI regions, showed higher DALY rates, reaching 189,563 and 165,080 per 100,000, respectively. The leading causes of death among the older included ischemic heart disease, stroke, COVID-19, and chronic obstructive pulmonary disease. The primary risk factors contributing to DALYs were high systolic blood pressure, air pollution, and tobacco use. The global disease burden among adults aged 70 and older has shown declines in death and DALY rates, yet remains a significant challenge exacerbated by population growth, especially in less developed regions. Implementing preventive strategies that target primary risk factors early and enhancing treatment of underlying conditions are crucial.

Open Access PDF

Concepts Keywords
Decades Aged
Disability Aged, 80 and over
Rapidly Aging
Causes of death
Disability-Adjusted Life Years
Female
Global disease burden
Global Health
Humans
Male
Older population
Risk Factors
Risk factors

Semantics

Type Source Name
disease MESH Death
disease MESH causes of death
disease MESH ischemic heart disease
disease MESH stroke
disease MESH COVID-19
disease MESH chronic obstructive pulmonary disease
disease IDO blood
drug DRUGBANK Medical air
pathway REACTOME Reproduction
disease MESH obstructive pulmonary disease
disease MESH high blood pressure
disease MESH chronic diseases
disease MESH Alzheimer’s disease
drug DRUGBANK Fenamole
disease MESH lifestyle factors
disease MESH infectious diseases
disease IDO process
disease MESH privacy
drug DRUGBANK Methionine
disease MESH non communicable diseases
disease MESH cardiovascular diseases
disease MESH causes
disease MESH ischemic stroke
drug DRUGBANK Dextrose unspecified form
disease MESH educational attainment
disease MESH uncertainty
drug DRUGBANK Vorinostat
drug DRUGBANK Ranitidine
disease MESH respiratory infections
disease MESH neoplasms
disease MESH respiratory diseases
disease MESH neurologic disorders
disease MESH dementias
disease MESH cardiomyopathy
disease MESH arthritis
disease MESH cognitive decline
disease MESH tic
disease MESH vascular diseases
disease MESH complications
disease MESH sedentary behavior
disease MESH chronic kidney disease
disease MESH diabetes mellitus
disease MESH heart disease
disease MESH obesity
disease MESH heart failure
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH valvular heart disease
disease MESH frailty
drug DRUGBANK Albendazole
drug DRUGBANK Adenosine 5′-phosphosulfate
disease IDO country
disease MESH metabolic diseases
pathway REACTOME Metabolism
disease IDO cell
drug DRUGBANK Trestolone

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *